Ledger.Open graph →
SEC Form D · filed September 17, 2025

Hopewell Therapeutics, Inc

Offering
$3.5M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WOBURN, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Xutian V. Jing · Woburn, MADirectorQiaobing V. Xu · Woburn, MAExec · DirectorNan V. Shen · Woburn, MADirectorC. T. Paschall · Woburn, MADirectorNan V. Shen · Woburn, MADirectorKjiel Carlson · El Segundo, CAExec · DirectorLiat Bycel · San Francisco, CADirectorThomas V. Hennessey, Iii · Wellesley, MADirectorXiaowen V. Femg · Woburn, MADirectorC. E. Springman · Bellevue, WAExec · DirectorSara Loewel · BROOKLYN, NYDirectorJonathan Reis · Wellesley, MADirectorThomas V. Hennessey, Iii · Wellesley, MADirectorXiaowen V. Femg · Woburn, MADirectorC. T. Paschall · Woburn, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗